Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocol

Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocol

Abstract Background The efficacy and safety of Lisdexamfetamine dimesylate (LDX) in the treatment of moderate to severe binge eating disorder (BED) has been demonstrated in multiple randomised clinical trials. Despite this, little is known about how LDX acts to improve binge eating symptoms. This st...

Full description

Bibliographic Details
Main Authors: Kristi R. Griffiths, Jenny Yang, Stephen W. Touyz, Phillipa J. Hay, Simon D. Clarke, Mayuresh S. Korgaonkar, Linette Gomes, Gail Anderson, Sheryl Foster, Michael R. Kohn
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Journal of Eating Disorders
Subjects:
Binge eating disorder
Clinical trials
Drug therapy
Neuroimaging
Online Access:http://link.springer.com/article/10.1186/s40337-019-0253-3

Internet

http://link.springer.com/article/10.1186/s40337-019-0253-3

Similar Items